Delivery Order SPE2DB20D2014-SPE2DB25FB09G

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,773.94 firm fixed-price delivery order is for the supply of PREMARIN 0.625 MG TABLET 1000S, a pharmaceutical product, with a performance period ending on February 14, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division,...
This federal contract award, valued at $9,382.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of PREMARIN 0.3 MG TABLET 1000S, a pharmaceutical product, with a period of performance through December 13, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,930.02 Firm Fixed Price delivery order is for the supply of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,619.41, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999 and running through November 2026. The award covers the procurement of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, for the federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,087.23 firm fixed-price delivery order is for the supply of PREMARIN 0.3 MG TABLET 100s, a pharmaceutical medication. The contract has an ultimate completion date of November 5, 2024. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,295.19 firm fixed-price delivery order is for the supply of PREMARIN 0.625 MG TABLET 100S, a hormone replacement medication. The award has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.44 firm fixed-price delivery order is for the supply of PREMARIN 0.3 MG TABLET 100S and has a contract type of Delivery Order with a period of performance through November 7, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,161.95 Firm Fixed Price Delivery Order is for the supply of PREMARIN 0.45 MG TABLET 100S to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PREMARIN 0.625 MG tablets. The $4,431.00 firm-fixed-price contract, which has no set-aside designation, is a delivery order that is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical. This IDC provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,400.87 fixed-price delivery order contract is for the supply of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB09G
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,426.30, is a Firm Fixed Price Delivery Order to provide PREMARIN 0.9 MG TABLET 100S medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of February 18, 2025.

Generated 5/16/25, 12:25 PM